From Inpatient to Home: Optimizing Transitions of Care for Patients on Long-Term Noninvasive Ventilation [0.03%]
从住院到居家：长期非侵入性通气患者的护理过渡优化
Fernando Figueroa Rodriguez,Alfredo Selim,Bernardo Selim
Fernando Figueroa Rodriguez
Noninvasive ventilation (NIV) is widely accepted as an intervention that helps patients with cardiopulmonary diseases and sleep-related breathing disorders transition from hospital to home. NIV can alleviate symptoms, normalize arterial blo...
Liz Timple,Sanil Gandhi,Robert L Owens et al.
Liz Timple et al.
Sleep in the hospital environment is often fragmented and suboptimal with particularly profound challenges in the ICU. Disruptions range from environmental factors, care interruptions, pharmacologic influences, and the sequelae of illness a...
Ashesha Mechineni,Tishena Nicole Lloyd,Ashima S Sahni et al.
Ashesha Mechineni et al.
Sleep disturbances during hospitalizations are common and its effect can translate into poor health and economic outcomes. Non pharmacological interventions remain the mainstay of recommended treatments and interventions. With the rise of n...
Inpatient Sleep Testing [0.03%]
住院睡眠监测
Gaurav Singh
Gaurav Singh
Inpatient sleep testing (IST) provides a unique although underused opportunity to improve access to care by identifying patients with sleep-disordered breathing (SDB) who may benefit from timely initiation of positive airway pressure (PAP) ...
Hospital Sleep Medicine [0.03%]
医院睡眠医学
Edward Rojas,Robert C Stansbury,Sunil Sharma
Edward Rojas
The integration of sleep medicine into hospital care is critical for addressing sleep-disordered breathing (SDB), a condition highly prevalent among hospitalized patients. Effective management of SDB is linked to improved patient outcomes, ...
K Ray Chaudhuri,Karolina Popławska-Domaszewicz
K Ray Chaudhuri
Clinical Personalized Medicine for Parkinson's Disease and Implications on Sleep Dysfunction [0.03%]
帕金森病的临床精准医疗及对睡眠障碍的意义
Vinod Metta,Karolina Popławska-Domaszewicz,Rosabel Chen et al.
Vinod Metta et al.
Personalized medicine (PM) for Parkinson's disease (PD) can range from precision genomic therapies such as ambroxol in glucocerebrosidase mutation-linked PD to treatment tailored for sleep dysfunction in nonmotor subtypes of PD. Additionall...
Transdermal, Infusion, and Surgical Therapies and Effect on Sleep Dysfunction in Parkinson's Disease [0.03%]
透皮、输液和外科治疗对帕金森病睡眠障碍的影响
Karolina Popławska-Domaszewicz,Raslan Ahmed,Riaan van Coller et al.
Karolina Popławska-Domaszewicz et al.
Sleep dysfunction is dominant in patients on oral dopamine replacement therapies as nighttime therapy is suboptimal and often not attempted. Non oral infusion-based Parkinson's disease (PD) therapies, transdermal therapies, as well as deep ...
Non-Pharmacologic Management Strategies to Manage Sleep Dysfunction in Parkinson's Disease [0.03%]
非药物策略管理帕金森病患者的睡眠障碍
Indu Subramanian,G A Glass,Aleksandar Videnovic et al.
Indu Subramanian et al.
Sleep concerns are ubiquitous among people with Parkinson's disease (PwP) and result in significant morbidity. Over 80% of PwP experience sleep disturbances and about 33% to 40% of these patients report that sleep issues are one of their mo...
Karolina Popławska Domaszewicz,Vinod Metta,Rosabel Chen et al.
Karolina Popławska Domaszewicz et al.
Sleep dysfunction can affect almost 90% of Parkinson's disease (PD) patients and insomnia related to fragmented sleep is common. Satisfactory management remains an unmet need although dopaminergic non-oral treatments utilising a continuous ...